Présentations

Présentations

Présentations

M. Touaibia. Structure Activity Relationship of Caffeic Acid Phenethyl Ester Analogs as New 5-lipoxygenase Inhibitors. 100th Canadian Chemistry Conference and Exhibition, Toronto, Canada, May 28-June 1, 2017.

M. Touaibia, A. Selka, N. A. Levesque, D. Foucher, O. Clarisse, F. Chemat. A Comparative Study of Solvent-Free and Highly Efficient Pinene Hydrogenation over Pd on Carbon, Alumina, and Silica Supports. 100th Canadian Chemistry Conference and Exhibition, Toronto, Canada, May 28-June 1, 2017.

M. Touaibia, P.-P. Roy, K. D'Souza, M. Cuperlovic-Culf, P. C. Kienesberger, New Atglistatin closely related analogues: synthesis and structure-activity relationship towards adipose triglyceride lipase. inhibition. Congrès annuel sur la recherché en santé au Nouveau Brunswick, Saint John, 02-03 Novembre 2016.

St-Coeur, P-D, Cormier, M., LeBlanc, V.C., Poitras, J., Touaibia, M. et Morin, P. Jr. octobre 2016, London, Canada. Exploring a series of MGMT inhibitors that can sensitize glioblastoma multiforme cells to temozolomide. Brain Tumour National Conference.

M. Touaibia, Natural products analogues with promising biological activities, Synthesis and structure-activity relationship. Conferences of Department of Chemistry, (Mars 2016) UNB, Fredericton, Canada.

Touaibia M, Doiron J, Hébèrt H, Cormier M, Levesque N A, Boudreau L H, Surette M E, Vogels C M, Westcott S A. (Juin 2015). Design and synthesis of new phenolic acid analogues as 5-lipoxygenase inhibitors. 98th Canadian Chemistry Conference and Exhibition, Ottawa, Canada.

Touaibia, M., Bhullar, K.S., Lassalle-Claux, G., Rupasinghe, H.P.V. Antihypertensive effect of caffeic acid analogs through dual renin-angiotensin aldosterone system. 6 Congrès annuel sur la recherché en santé au Nouveau Brunswick. Moncton, 13-14 Novembre 2014

Touaibia, M. Nouvelles molécules avec des activités anti-inflammatoires et antibactériennes. Faculté des sciences, Université de Tlemcen, Algérie, 28 Septembre 2014.

Touaibia, M. Conception de nouvelles molécules avec des activités antibactériennes et anti-inflammatoires. Faculté des sciences des aliments, Université de Boumerdesse, Algérie, 21 Septembre 2014.

Touaibia, M. Nouveaux analogues de produits naturels dotés d’activités antibactériennes et anti-inflammatoires. Faculté des sciences, Université d'Avignon, Avignon, France, 19 Septembre 2014.

Touaibia, M. Nouvelles alternatives aux antibiotiques et anti-inflammatoires classiques. Est-ce possible? Conférences MidiSciences, Université d'Avignon, Avignon, France, 18 Septembre 2014.

Touaibia, M. Design and synthesis of new molecules with antibacterial activities. Drug Design Day, Université d’Aix-Marseille, France, 16 Septembre 2014.

St-Cœur, P-D, Poitras J.J., LeBlanc, V., Cuperlovic-Culf, M., Touaibia, M. and Morin, P. Jr. Glioblastoma Multiforme and MGMT inhibition : Temozolomide Resistance Identification by a metabolomic approach. BHCRI 5th Cancer Research Conference in Atlantic Canada, November 2014, Halifax.

LeBlanc V., St-Coeur, P-D., Belbraouet, Touaibia, M. and Morin P. Jr. Promising New MGMT Inhibitors for the Treatment of Temozolomide Resistant Glioblastomas. BHCRI 5th Cancer Research Conference in Atlantic Canada, November 2014, Halifax.

Poitras, J., Morin, P. Jr. and Touaibia, M. Synthesis and Characterization of STAT3 Inhibitors in GBM Cells. BHCRI 5th Cancer Research Conference in Atlantic Canada, November 2014, Halifax.

Cuperlovic-Culf, M.; Kaplan, L.; Lloyd, V.; Touaibia, M.; Boyle, K.; Wang, L.; Forseille, L.; Francis, T.; Buhrow, L.; Merkley, N.; Loewen, M.; Fobert P. Metabolomics and Metaboloepigenomics of Wheat-Fusarium Head Blight Interaction. XVI International Congress on Molecular Plant-Microbe Interactions, July 2014, Rhodes, Greece.

St-Coeur, P-D, Poitras, J, Cuperlovic-Culf, A, Touaibia, M et Morin, P. Jr. Avril 2013, Moncton. Diagnosing temozolomide resistance in glioblastomas using metabolomics. Brain Tumour Foundation of Canada Seminar Series.

Bhullar KS, Lassalle-Claux G, Touaibia M, Rupasinghe HPV. Juillet 2013, Antigonish, Nova Scotia. Antihypertensive activity of caffeic acid derivatives via inhibition of angiotensin converting enzyme (ACE) and renin in vitro. Maritime Natural Products Conference, , 2013-07-12

Sanderson T, Clabault H, Patton C, LeBlanc L, Hébert M, Touaibia M. 52nd Annual Meeting, March 10-14, 2013, San Antonio, Texas, USA. Antiproliferative, antiandrogenic and cytotoxic effects of novel derivatives of caffeic acid in LNCAP human androgen-dependent prostate cancer cells.

P. A. Do, M. Touaibia, and A. Haché. Conference on Lasers and Electo-optics (CLEO) 2013, San Jose, USA. Edge self-interference of a laser beam and application to thin film metrology.

T.V. Son, M. Touaibia, and A. Haché. American Physical Society March meeting, Baltimore, paper N46.00003 (2013). Thermal expansion measurement using optical grating diffraction shifts.

P.A. Do, M. Touaibia, and A. Haché. American Physical Society March meeting, Baltimore, paper H1.00165 (2013). Surface temperature measurement by optical self-interference of laser beam at the edge of a thermally sensitive thin film.

P-D. St-Coeur, D. Ferguson, M. Touaibia, P. Jr. Morin, NBHRF 4th Annual Health Research Conference. 7-8 Novembre 2012, Fredericton. PF-8380 and closely related analogues synthesis, structure -activity relationship towards autotaxin inhibition and glioma cell viability.

N. Lefort, A. Brown, V. Lloyd, R. Ouellette, M. Touaibia, A. Culf, M. Cuperlovic-Culf. NBHRF 4th Annual Health Research Conference.7-8 Novembre 2012, Fredericton. The effect of DCA and allopurinol on breast cancer viability.

M. Touaibia, NBHRF 4th Annual Health Research Conference. 7-8 Novembre 2012, Fredericton (Conférencier invité). Phenolic acids analogues with promising biological activities, Synthesis and structure-activity relationship.

Touaibia, M.; Soultan, A.H.; Doiron, J.; Richard, R.; Picot, N.; Richard, R.; Cuperlovic-Culf, M.; Robichaud, G.A. 243rd ACS National Meeting & Exposition, San Diego, CA, United States, March 25-March 29, 2012). Substituted 1,2,3-triazole letrozole-based analogs as aromatase inhibitors.